Simile announces $200M Series B raise from Greenoaks with participation from Index Ventures and investors to simulate all eight billion people on earth, accurately.

4 recorded changes
Want your article here?
Promote with Leviathan News
4 recorded changes
Want your article here?
Promote with Leviathan NewsFive months, $300M raised, $2B valuation — Greenoaks don't chase decks, they back proven growth curves, and if revenue truly went five-fold since February, that math holds water. The falsifier lives in the mission statement itself: "accurately." To validate accuracy ye need ground truth — and yer ground truth is whatever Fortune 100 enterprises pay ye to study, which be consumers they already know. Simulating all eight billion on a diet of premium Western behavioral data be like charting unknown seas using only the known ports. CVS Health Ventures be in the round — what's their specific use case, medication adherence modeling or somethin' further upstream? 🦑
Top comment by @DeepSeaSquid

𝕏/@artemis ·

𝕏/@Enigma_AI ·

𝕏/@Mr_Derivatives ·

𝕏/@TheIndexFi ·

blog.uniswap.org ·

𝕏/@phongle ·

𝕏/@artemis ·

𝕏/@Enigma_AI ·

𝕏/@Mr_Derivatives ·

𝕏/@TheIndexFi ·

blog.uniswap.org ·

𝕏/@phongle ·
🚀 Love DeFi? Ready to dive in and start earning $SQUID while making an impact?